Instrumento Inactivo

Otros idiomas Therapix Biosciences Ltd TEL AVIV STOCK EXCHANGE

Acciones

TRPX

IL0010951403

Precio de cierre TEL AVIV STOCK EXCHANGE Otros sitios de cotización
- ^ILS	-

03/06	SciSparc Ltd. Se asegura una ventaja estratégica con la concesión de una patente europea	CI
01/04	SciSparc Ltd. Resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

SciSparc : Report Of Foreign Private Issuer Form 6 K	14/06
SciSparc Ltd. Secures Strategic Advantage with Grant of European Patent	03/06
SciSparc Secures Strategic Advantage with Grant of European Patent	31/05
SciSparc to Acquire AutoMax	11/04
SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd.	11/04
Tranche Update on SciSparc Ltd.'s Equity Buyback Plan announced on July 7, 2022.	01/04
SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research	21/03
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	18/03
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	18/03
SciSparc Ltd. Receives Another Patent, Strengthening its Core Technology in Canada	18/03
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial	14/03
SciSparc Ltd. Announces Successfully Dosed the First Patient in Its SCI-210 Clinical Trial At the Soroka Medical Center for Pediatric Patients	14/03
SciSparc : MitoCareX Update - Form 6-K	13/03
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	12/03
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	12/03
Top Premarket Gainers	08/03
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	08/03
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	08/03
SciSparc Ltd. Announces Enrollment of First Patient for Its Clinical Trial for Children with Autism Spectrum Disorder	08/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Therapix Biosciences Ltd TEL AVIV STOCK EXCHANGE

Acciones

TRPX

IL0010951403

Otros idiomas

Filtros